TY - JOUR T1 - Dopamine D1-like receptor blockade and stimulation decreases operant responding for nicotine and food in male and female rats JF - bioRxiv DO - 10.1101/2022.01.24.477590 SP - 2022.01.24.477590 AU - Ranjithkumar Chellian AU - Azin Behnood-Rod AU - Ryann Wilson AU - Karen Lin AU - Grace Wing-Yan King AU - Marcella Ruppert-Gomez AU - Alexandria Nicole Teter AU - Adriaan W. Bruijnzeel Y1 - 2022/01/01 UR - http://biorxiv.org/content/early/2022/01/27/2022.01.24.477590.abstract N2 - Dopamine has been implicated in smoking, but there remains a need for a better understanding of the effects of dopamine D1-like receptor agonists on nicotine intake and the role of sex in the effects of dopaminergic drugs on nicotine intake. This work studied the effects of D1-like receptor stimulation and blockade on operant responding for nicotine and food and locomotor activity in male and female rats. The effects of the D1-like receptor antagonist SCH 23390 (0.003, 0.01, 0.03 mg/kg) and the D1-like receptor agonist A77636 (0.1, 0.3, 1 mg/kg) on responding for nicotine and food, and locomotor activity were investigated. The effects of SCH 23390 were investigated 15 min and 24 h after treatment, and the effects of the long-acting drug A77636 were investigated 15 min, 24 h, and 48 h later. Operant responding for nicotine and food was decreased 15 min, but not 24 h, after treatment with SCH 23390. Operant responding for nicotine was decreased 15 min, 24 h, and 48 h after treatment with A77636, and food responding was decreased 15 min and 24 h later. Locomotor activity was decreased 15 min, but not 24 h, after treatment with SCH 23390. A77636 only decreased locomotor activity 48 h after treatment. There were no sex differences in the effects of SCH 23390 or A77636. In conclusions, the D1-like receptor antagonist SCH 23390 reduces nicotine intake and causes sedation in rats. Stimulation of D1-like receptors with A77636 decreases nicotine intake at time points that the drug is not sedative.Competing Interest StatementThe authors have declared no competing interest. ER -